MedTrace Logo

Development of a Prenatal Test for Fetal Aneuploidy Detection

NCT01451671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2020-04-30

No results posted yet for this study

Summary

This is an observational study to develop and evaluate a blood based prenatal blood test. Pregnant women confirmed to be carrying a fetus with a chromosomal abnormality will be eligible. Subjects will be asked to provide a blood sample and a limited amount of clinical data that will be recorded on a case report form. All samples and clinical data will be stripped of subject identifiers prior to submission to Ariosa.

Conditions

  • Fetal Complications

Sponsors & Collaborators

  • Cindy Cisneros

    lead INDUSTRY

Principal Investigators

  • Tracy Roberts · Ariosa Diagnostics

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01451671 on ClinicalTrials.gov